|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.370 USD | 0.00% |
|
+2.60% | +31.67% |
| 13/05 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 13/05 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | +2.60% | +9.22% | +10.75% | +31.67% | +48.12% | +42.77% | +50.96% | -62.99% | 19Cr | |
| +0.86% | +2.30% | +8.03% | +30.34% | +11.29% | +49.71% | +158.86% | +389.88% | +1,365.90% | 1,05700Cr | |
| +1.59% | +5.37% | +10.17% | +14.20% | +27.28% | +55.77% | +54.77% | +53.33% | +110.67% | 62TCr | |
| +0.95% | +1.95% | +10.48% | +29.07% | +13.51% | +36.11% | +80.44% | +119.44% | +306.46% | 45TCr | |
| +1.60% | +7.09% | +9.19% | +9.30% | +8.20% | +35.90% | +29.32% | +2.25% | +42.15% | 34TCr | |
| -0.60% | +2.95% | +2.82% | +9.13% | +15.78% | +36.28% | +39.04% | +50.05% | +54.10% | 30TCr | |
| -0.14% | +0.33% | -6.77% | -12.57% | -8.12% | +18.70% | +17.64% | +49.41% | +174.69% | 26TCr | |
| +0.09% | -4.53% | +4.18% | +29.96% | -1.43% | -27.60% | -42.19% | +12.31% | +70.99% | 22TCr | |
| +1.22% | +1.20% | +8.37% | +7.87% | +14.89% | +21.61% | +60.14% | +51.80% | +126.98% | 20TCr | |
| -1.18% | -5.13% | +3.41% | -3.24% | +5.35% | +13.87% | +60.35% | +87.35% | +49.40% | 16TCr | |
| -0.16% | -2.39% | -0.73% | -7.99% | -1.45% | -3.23% | -34.39% | -41.12% | -33.21% | 14TCr | |
| +0.94% | +2.61% | +11.81% | +5.20% | +15.11% | +26.77% | -4.00% | -9.15% | -17.96% | 13TCr | |
| +0.90% | -1.78% | +1.91% | +9.71% | +5.29% | +0.09% | +31.70% | +138.08% | +408.42% | 12TCr | |
| -0.43% | -1.18% | +3.48% | -7.01% | -8.09% | -10.18% | -22.90% | -13.67% | -0.74% | 10TCr | |
| +0.73% | -1.87% | -1.94% | -7.54% | +5.21% | +39.96% | +38.27% | +8.45% | -7.47% | 10TCr | |
| +2.83% | +2.42% | -0.24% | -16.92% | -10.03% | +4.20% | +85.08% | +79.69% | +470.46% | 7.24TCr | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 6.37TCr | |
| +2.60% | +5.67% | +12.71% | +5.95% | +16.81% | +29.99% | +28.74% | +52.24% | +26.69% | 5.36TCr | |
| -2.66% | -4.54% | +9.13% | -5.23% | -10.27% | -6.44% | +16.37% | -13.08% | +242.08% | 5.35TCr | |
| -0.30% | -3.48% | +19.33% | +15.03% | +24.45% | +61.76% | -11.32% | -10.04% | -49.97% | 5.16TCr | |
| Average | +0.28% | +0.10% | +6.03% | +6.11% | +8.18% | +22.70% | +33.09% | +55.69% | +172.46% | 22.51TCr | |
| Weighted average by Cap. | +0.11% | +1.11% | +6.50% | +14.20% | +10.57% | +32.21% | +64.33% | +128.85% | +420.08% |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
